Literature DB >> 17984315

Lenalidomide-induced severe hepatotoxicity.

Subuhee Hussain, Royston Browne, Julie Chen, Samir Parekh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17984315     DOI: 10.1182/blood-2007-06-097758

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

Review 1.  Lenalidomide-induced acute liver failure.

Authors:  Pankaj Jain
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

2.  Post-allograft pomalidomide and reversible hepatotoxicity.

Authors:  J M Pauff; R S Gonzalez; K P Sajnani; A Kassim; M Jagasia
Journal:  Bone Marrow Transplant       Date:  2014-06-23       Impact factor: 5.483

3.  Lenalidomide induced intrahepatic cholestasis in newly diagnosed patients of multiple myeloma.

Authors:  Rabindra Kumar Jena; Trupti Rekha Swain; Sandeep Sadashivrao Kansurkar; Manorama Swain
Journal:  Eur J Clin Pharmacol       Date:  2011-11-30       Impact factor: 2.953

Review 4.  The use of novel agents in multiple myeloma patients with hepatic impairment.

Authors:  Lindsay C Stansfield; Wilson I Gonsalves; Francis K Buadi
Journal:  Future Oncol       Date:  2015       Impact factor: 3.404

5.  Development of rapid light-chain deposition disease in hepatic arteries with severe ischemic cholangitis in a multiple myeloma patient treated with melphalan, prednisone and lenalidomide.

Authors:  Katja C Weisel; Michael Böckeler; Leonardo Bianchi; Luigi M Terracciano; Frank Mayer; Lothar Kanz
Journal:  Int J Hematol       Date:  2008-12-20       Impact factor: 2.490

6.  A Case of Drug-Induced Hepatitis due to Lenalidomide.

Authors:  M-C Zanella; L Rubbia-Brandt; E Giostra; Y Chalandon; A Hadengue; L Spahr
Journal:  Case Rep Gastroenterol       Date:  2011-04-13

Review 7.  Use of lenalidomide in the management of relapsed or refractory multiple myeloma: expert recommendations in Korea.

Authors:  Hyo Jung Kim; Sung-Soo Yoon; Hyeon Seok Eom; Kihyun Kim; Jin Seok Kim; Je-Jung Lee; Soo-Mee Bang; Chang-Ki Min; Joon Seong Park; Jae-Hoon Lee
Journal:  Blood Res       Date:  2015-03-24

8.  Current awareness: pharmacoepidemiology and drug safety.

Authors: 
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-06       Impact factor: 2.890

9.  Practical approaches to the use of lenalidomide in multiple myeloma: a canadian consensus.

Authors:  Donna Reece; C Tom Kouroukis; Richard Leblanc; Michael Sebag; Kevin Song; John Ashkenas
Journal:  Adv Hematol       Date:  2012-10-14

10.  Hyperbilirubinemia following lenalidomide administration.

Authors:  Veronica Azmy; Natalia Neparidze
Journal:  Clin Case Rep       Date:  2018-03-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.